Results 1 to 10 of about 307,775 (306)
Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery
Asthma and chronic obstructive pulmonary disease (COPD) are pulmonary diseases that are characterized by inflammatory cell infiltration, cytokine production, and airway hyper-reactivity. Most of the effector cells responsible for these pathologies reside
Chiang Po-Chang +5 more
doaj +1 more source
Drug-induced changes in cardiac contractility (inotropy) can lead to cardiotoxicity, a major cause of discontinuation in drug development. Preclinical approaches to assess cardiac inotropy are imperfect, with in vitro assays limited to stem cell-derived ...
Cristian Trovato +8 more
doaj +1 more source
Strategies to deliver peptide drugs to the brain [PDF]
Lalatsa, Katerina +2 more
core +1 more source
Three-dimensional (3D) cell culture models, particularly spheroids, have emerged as promising alternatives to animal models for preclinical drug evaluation.
Tahoora Naseri +4 more
doaj +1 more source
According to the Federal Law «On Biomedical Cell Products», preclinical trials are an integral part of biomedical cell product (BCP) development. This article describes the basic principles of fulfilling requirements laid down in the Rules for conducting
E. V. Melnikova +3 more
doaj
A hallmark of Alzheimer's disease (AD) is the extracellular aggregation of toxic amyloid-beta (Aβ) peptides in form of plaques. Here, we identify netoglitazone, an antidiabetic compound previously tested in humans, as an Aβ aggregation antagonist ...
Francesca Catto +13 more
doaj +1 more source
Precision oncology in the age of AI: lessons from AI-driven drug discovery and clinical translation. [PDF]
Yoo W.
europepmc +1 more source
Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: Feasibility of an antibody-based companion diagnostic agent [PDF]
Dehdashti, Farrokh +12 more
core +2 more sources
P046: Preclinical evaluation of novel repurposed drug combinations in Hodgkin lymphoma
Mia Lohmann +10 more
doaj +1 more source
When Selectivity Increases Uncertainty: Context-Dependent Pharmacology in Antibody Drug Development. [PDF]
Liao X, Cao Y.
europepmc +1 more source

